| Title | Rapid Onset of Response Observed with Certolizumab Pegol in Rheumatoid Arthritis Patients with Inadequate Response to Methotrexate: Efficacy and Safety Results of a Randomized, Double-Blind, Placebo-Controlled Phase 3 Study |
| Authors | Bi, Liqi Li, Yuhui He, Lan Xu, Huji Gu, Jieruo Wang, Guochun Zhang, Zhiyi Liu, Yi Boehnlein, Marion Dunkel, Jochen Shao, Jing Harris, Kristina Li, Zhanguo |
| Affiliation | Jilin Univ, China Japan Union Hosp, Changchun, Jilin, Peoples R China. Peking Univ, Peoples Hosp, Beijing, Peoples R China. Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China. Shanghai Changzheng Hosp, Shanghai, Peoples R China. Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China. China Japan Friendship Hosp, Beijing, Peoples R China. Harbin Med Univ, Affiliated Hosp 1, Harbin, Heilongjiang, Peoples R China. Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China. UCB Pharma, Monheim, Germany. UCB Pharma, Tokyo, Japan. UCB Pharma, Slough, Berks, England. |
| Keywords | MULTICENTER REMISSION |
| Issue Date | 2017 |
| Publisher | ARTHRITIS & RHEUMATOLOGY |
| Citation | ARTHRITIS & RHEUMATOLOGY. 2017, 69. |
| URI | http://hdl.handle.net/20.500.11897/484786 |
| ISSN | 2326-5191 |
| Indexed | SCI(E) |
| Appears in Collections: | 人民医院 |
